What is Invuity's stock symbol?
Invuity trades on the NASDAQ under the ticker symbol "IVTY."
Where is Invuity's stock going? Where will Invuity's stock price be in 2017?
5 analysts have issued 1-year price targets for Invuity's stock. Their predictions range from $9.00 to $25.00. On average, they anticipate Invuity's stock price to reach $15.80 in the next year.
When will Invuity announce their earnings?
Invuity is scheduled to release their next quarterly earnings announcement on Wednesday, February, 22nd 2017.
What are analysts saying about Invuity stock?
Here are some recent quotes from research analysts about Invuity stock:
According to Zacks Investment Research, "Invuity, Inc. is a medical technology company. Its products include Eikon Illuminated Retractor System, Saber Yankauer, Saber Frazier, Eika Illuminated Retractor System, Breiten Illuminated Retractor System, Eipex Illuminated Retractor System, Eivector Illuminated Retractor System and Waveguide XT System. The Company sells its devices through its direct sales representatives and original equipment manufacturers of surgical systems. Invuity, Inc. is based in San Francisco, California. " (2/17/2017)
- Stifel Nicolaus analysts commented, "Following Invuity's early January top-line pre-announcement giving a potential $9.1M-$9.3M revenue range, the company's full 4Q16 release and call provided both more positive details on the quarter and critical revenue measures, all of which suggests the business has stabilized after slower than expected 3Q16 results. At $9.4M, 4Q16 sales were a touch ahead of the company's preliminary range. Encouragingly, revenue per account at $12,100 (+10% Y/Y, 5% Q/Q) -- a critical measure for assessing the company's "go-deep" strategy -- appears stable. Equally impressive, the company continued to expand its active hospital account base which now stands at 745 (+41% Y/Y). Management again reaffirmed 2017 top-line guidance of $42M-$44M, which, in our view, could prove conservative given 4Q16 stable revenue/account, new accounts adds, and "modest" contribution from the mid-year 2017 expected full launch of PhotonBlade. We continue to believe Invuity's highly differentiated, and expanding, portfolio of procedure enhancing technologies will continue to demonstrate meaningful growth potential across a broad array of medical specialties. At current valuation levels, 1.6x 2018 EV/R (peer group: ~3.0x), Invuity would appear undervalued, given the company's significant top-line growth outlook. We rate Invuity shares Buy with a now higher $9 (from $8) target price." (2/15/2017)
Who owns Invuity stock?
Invuity's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Deerfield Management Co. (9.99%), Deerfield Mgmt, LP (9.98%), Novo A S (7.79%), Interwest Venture Management Co. (6.38%), FMR LLC (4.87%) and Kingdon Capital Management L.L.C. (4.27%). Company insiders that own Invuity stock include Alex Vayser, Eric W Roberts, Gregory T Lucier, James E Flynn, James H Mackaness, Philip M Sawyer and Robert Gerberich.
Who sold Invuity stock? Who is selling Invuity stock?
Invuity's stock was sold by a variety of institutional investors in the last quarter, including FMR LLC and Wall Street Associates. Company insiders that have sold Invuity stock in the last year include Alex Vayser, Eric W Roberts, James E Flynn, Philip M Sawyer and Robert Gerberich.
Who bought Invuity stock? Who is buying Invuity stock?
Invuity's stock was acquired by a variety of institutional investors in the last quarter, including Interwest Venture Management Co., Deerfield Management Co., Lyon Street Capital LLC, Kingdon Capital Management L.L.C., Alyeska Investment Group L.P., Discovery Group I LLC, RTW Investments LP and Novo A S. Company insiders that have bought Invuity stock in the last two years include Gregory T Lucier and James H Mackaness.
How do I buy Invuity stock?
Shares of Invuity can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Invuity stock cost?
One share of Invuity stock can currently be purchased for approximately $8.10.